Jim Simons Xenetic Biosciences, Inc. Transaction History

Renaissance Technologies LLC

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 12, 2023	SELL	$0.31 - $0.73 $13,606 - $32,041	-43,893 Reduced 30.61%	99,507 $40,000
Q4 2022 Feb 13, 2023	BUY	$0.27 - $5.75 $7,641 - $162,725	28,300 Added 24.59%	143,400 $41,000
Q3 2022 Nov 14, 2022	SELL	$0.59 - $5.57 $21,215 - $200,286	-35,958 Reduced 23.8%	115,100 $62,000
Q2 2022 Aug 12, 2022	SELL	$0.6 - $1.14 $24,209 - $45,997	-40,349 Reduced 21.08%	151,058 $121,000
Q1 2022 May 13, 2022	SELL	$0.88 - $1.37 $61,438 - $95,647	-69,816 Reduced 26.73%	191,407 $195,000
Q4 2021 Feb 11, 2022	SELL	$1.27 - $2.08 $200,237 - $327,947	-157,667 Reduced 37.64%	261,223 $337,000
Q3 2021 Nov 12, 2021	BUY	$1.73 - $5.3 $480,367 - $1.47 Million	277,669 Added 196.62%	418,890 $859,000
Q2 2021 Aug 13, 2021	SELL	$1.57 - $2.45 $172,586 - $269,323	-109,928 Reduced 43.77%	141,221 $288,000
Q1 2021 May 13, 2021	BUY	$2.01 - $3.5 $162,707 - $283,321	80,949 Added 47.56%	251,149 $548,000
Q4 2020 Feb 10, 2021	BUY	$0.79 - $3.17 $87,682 - $351,841	110,991 Added 187.46%	170,200 $347,000
Q3 2020 Nov 13, 2020	SELL	$0.83 - $1.56 $94,610 - $177,821	-113,988 Reduced 65.81%	59,209 $54,000
Q2 2020 Aug 13, 2020	BUY	$0.71 - $1.31 $6,446 - $11,894	9,080 Added 5.53%	173,197 $177,000
Q1 2020 May 14, 2020	BUY	$0.49 - $1.69 $21,225 - $73,205	43,317 Added 35.86%	164,117 $122,000
Q4 2019 Feb 13, 2020	BUY	$1.05 - $1.66 $126,840 - $200,528	120,800 New	120,800 $174,000

Ticker XBIO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 15,166,600
Market Cap $65.1M
Description
Xenetic Biosciences, Inc., a biopharmaceutical company, focuses on advancing XCART, a personalized chimeric antigen receptor T cell (CAR T) platform technology engineered to target patient-specific tumor neoantigens. The company engages in the discovery, research, and development of biologic drugs and oncology therapeutics. It advances cell-base...

Get notified when there are updates to the investment portfolio of Renaissance Technologies LLC, based on Form 13F filings with the SEC.

Stay updated on Renaissance Technologies LLC and Jim Simons with notifications on news.